ABSTRACT
INTRODUCTION
Standardization and quality control (QC) of fetal ultrasound biometry are essential to ensure high levels of reproducibility among operators and ultrasound facilities. This applies particularly to multicenter studies because reproducibility and measurement consistency, among even well-trained sonographers, improve as a result of introducing QC systems 1 . Unfortunately, however, a common failing in this field is a complete absence of QC systems; for example, in studies designed to create charts for pregnancy dating and for fetal and neonatal growth [2] [3] [4] [5] . Although the effects of QC on measurement reproducibility have been demonstrated in research settings, their relevance may be even greater in routine clinical practice because measurement accuracy is critical for detecting abnormal fetal growth patterns, especially in the absence of blinding of the sonographer to measurements. In fact, avoiding false-positive findings, which are associated with attendant anxiety and risk of unnecessary interventions 6 , is almost as important in antenatal care as are diagnostic failures.
For a QC system in fetal biometry to be useful clinically, multiple strategies need to be employed 7 , such as (1) qualitative scoring of ultrasound images against predefined criteria 8 and (2) quantitative assessment of measurements and comparison with their expected distributions as, for example, occurs in fetal nuchal translucency QC [9] [10] [11] [12] [13] , although, until now, these approaches have largely been utilized only in small studies [8] [9] [10] 13, 14 . In this study, we describe and assess the value of the comprehensive QC package used in the Fetal Growth Longitudinal Study (FGLS) of the INTERGROWTH-21 st Project.
METHODS
Women at low risk of adverse pregnancy outcome were recruited into FGLS, one of the three main components of st Project (www.intergrowth21 .org.uk), a multicenter, multicountry, population-based project, conducted between 2008 and 2014 in eight countries 5, 15, 16 , which aimed to construct international fetal growth standards. Serial ultrasound scans were performed every 5 ± 1 weeks from 14 + 0 to 41 + 6 weeks' gestation. Gestational age was calculated on the basis of the last menstrual period (LMP) provided that (1) it was known and certain, (2) the menstrual cycles were regular, (3) there was no hormonal contraceptive use or breastfeeding during the 2 months prior to natural conception and (4) standardized 17 ultrasound measurement of fetal crown-rump length between 9 + 0 and 13 + 6 weeks' gestation agreed with the LMP-based estimate of gestational age within 7 days 18 .
At each examination, three fetal biometric variables (head circumference (HC), abdominal circumference (AC) and femur length (FL)) were measured in triplicate on separately generated two-dimensional ultrasound images. Thus, each examination produced nine measurements (three per variable) in accordance with the study protocol (www.intergrowth21.org.uk) 19 .
All sonographers were recruited on the basis of being motivated, reliable and trained in ultrasound as well as having the abilities to speak the local language(s) and work positively within a team structure. The goals of standardization were, firstly, to ensure that all sonographers understood fully the study protocol and took measurements in an identical fashion, and, secondly, that they were familiar with the equipment used. The precise details of how measurements were taken for FGLS and how data collection was standardized (through training, assessment and certification of all the sonographers) are presented in full elsewhere 7, 19 . Head measurements were obtained in the transthalamic plane, placing the calipers on the outer border of the skull, using both the ellipse facility and two perpendicular diameters. Abdominal measurements were obtained in an axial plane, with the umbilical vein in the anterior third of the fetal abdomen (at the level of the portal sinus) and the stomach bubble visible. Again, both the ellipse facility and the two-diameters method were used, placing the calipers on the outer border of the body outline (skin covering). In this study, we elected to analyze only the HC and AC measurements obtained using the ellipse facility, as a previous study showed that these were almost identical to those obtained using the two-diameters method, but marginally more reproducible 20 . For FL, the femur closest to the probe was measured with its long axis as horizontal as possible. Calipers were placed on the outer borders of the diaphysis of the femoral bone ('outer to outer').
All ultrasound scans were performed using the same commercially available ultrasound machine (Philips HD-9, Philips Ultrasound, Bothell, WA, USA) with curvilinear abdominal transducers (C5-2, C6-3 and V7-3).
During the INTERGROWTH-21
st Project, blinding of operators to the measurement value was undertaken, thus eliminating expected-value bias. For this purpose, the manufacturer programmed the machine's software so that the measurement values did not appear on-screen during a scan. The adopted QC strategies, which are described in detail below, included qualitative (i.e. image scoring) and quantitative (i.e. estimating intra-and interobserver variability, and standard deviations (SD) of triplicate measures) analyses for each biometric variable. Six sonographers undertook QC at the Oxford-based Ultrasound Quality Unit (USQU); any uncertainties were adjudicated by the QC Director (A.T.P.). The analyses were performed monthly for the first 18 months of each site's participation and quarterly thereafter, or more frequently if any QC concerns were raised so as to identify sonographers performing outside accepted norms to allow corrective action (e.g. retraining) to be administered promptly 7 .
Qualitative QC: image scoring
Images were scored 7, 8 based on a set of criteria, each worth 1 point towards the total score, with a maximum of 6 points for HC and AC, and 4 points for FL (Table 1) . All images were self-scored at the time of scanning by the sonographer taking the image. A randomly chosen sample of 10% of all these images was rescored by a sonographer at the USQU; the highest of these three scores was used in the QC analysis. In order to simplify the comparison between self-and USQU scoring, we divided data into low-scoring (1-3 for HC and AC, and 1-2 for FL) and high-scoring (4-6 for HC and AC, and 3-4 for FL) images 7 . As the quality was generally very good, higher scores were much more prevalent than lower scores; comparison between self-and USQU scoring was therefore undertaken using an adjusted kappa statistic (interobserver variability of image scoring) to account for the resulting unbalanced distributions of scores 21 . A kappa value of more than 0.6 was considered a priori as an acceptable level of agreement among sonographers.
Quantitative QC: intra-and interobserver variation
As triplicate images and measurements were taken for each fetal biometric variable (HC, AC, FL), the intraobserver variability of the measurements could be assessed in the full dataset using Bland-Altman plots 22 . Instead of simply expressing differences within observers as actual measurement units (mm), pairwise comparisons were also made in percentage terms to account for changes in fetal size with increasing gestational age. The difference between two selected measurements was calculated and expressed as a percentage of their mean, then plotted against this mean. The 95% limits of agreement (LoA) were calculated and marked on the plots, giving a quantifiable estimate for measurement variability within the same observer associated with acquiring an image and positioning the calipers. These plots were generated by randomly selecting two of the three triplicate measurements taken at each scan for each biometric variable.
Actual (mm) and percentage difference Bland-Altman plots were also used to assess the interobserver variability of the measurements. As above, a sonographer at the USQU remeasured a random sample of 10% of all images from each site. The difference between the original and USQU measurements was expressed both as the actual value and as a percentage of their mean, then plotted against this mean. Again, 95% LoA were calculated and marked on the plots, giving a quantifiable estimate for the measurement reproducibility between observers associated with caliper placement.
Quantitative QC: data distribution
The SD of each measurement triplet was expressed as a percentage of the mean of the three measurements, enabling each sonographer's individual variability to be compared with the expected variability 14 whilst accounting for changes in fetal size with increasing gestational age.
Plotting each sonographer's SDs as separate frequency histograms allowed identification of those whose SD distributions differed from those of the expected range, based on the equivalent data derived from an initial variability study 14 . Sonographers demonstrating disproportionately large numbers of triplets outside the expected variability distribution were identified, causes investigated and retraining undertaken if necessary. Each sonographer's SDs were also plotted sequentially on a cumulative sum-control chart 7, 14 to identify triplets with values > 2 SD from the mean more than 10% of the time.
All QC performed by USQU sonographers was undertaken blinded to the study site, sonographer identity, original measurement and their own repeated measurements. Unblinding occurred only to provide feedback to sonographers where necessary. All plots were generated and analyses performed using SAS software (SAS Institute Inc., Cary, NC, USA).
The INTERGROWTH-21 st Project protocol was approved by the Oxfordshire Research Ethics Committee C (reference: 08/H0606/139); all enrolled pregnant women gave informed written consent.
RESULTS
We studied 4321 singleton fetuses, the intrauterine biometric measurements from which were used to construct international fetal growth standards, and all of which were born alive without congenital malformations 18 . Each fetus had a median of 5 (range 1-7; mean ± SD 4.9 ± 0.8; total 20 313) scans. Figure 1 shows the total number of scans eligible for QC for each biometric variable (HC, AC and FL) after excluding measures >5 SD from the mean and missing data.
Between 20 040 and 20 313 scans, depending on the biometric variable, were assessed for intraobserver variability (Figure 1 ). Of the 17 350 scans performed at sites other than Oxford, 10% (n = 1735) were selected randomly for external image rescoring and remeasurement by an USQU sonographer. Of these, 122 scans could not be assessed (due to incomplete backup of images or data lost due to corruption of the backup file) leaving 1613 scans from 1322 women who underwent QC by USQU sonographers (Figure 1 ).
Qualitative QC: image scoring
Of the 1613 scans, 1340 (83.1%) were rescored; the remainder were missing original image scores (n = 256) or rescorings were not logged (n = 17). Overall, the quality of all measurements was high. The median self-scored image values for HC, AC and FL were 6 (interquartile range (IQR), 6-6), 6 (IQR, 6-6) and 4 (IQR, 4-4), respectively -the maximum values in the scoring system. There was a very high level of agreement between the self-and external scoring of image quality for all measurements, with adjusted kappa values of 0.99 (95% CI, 0.98-0.99) for HC, 0.98 (95% CI, 0.97-0.99) for AC and 0.96 (95% CI, 0.95-0.98) for FL ( Table 2 ). In almost all cases, both the local and USQU sonographers classified the same image as high-scoring (99% scored 4-6 for HC and AC, 98% scored 3-4 for FL). This external image assessment process resulted in six sonographers requiring retraining over the entire study period, after which improvements in performance were seen.
Quantitative QC: intra-and interobserver variation
Intraobserver variability was assessed using all 20 313 scans, comparing two of the triplicate measurements for each scan, selected randomly and in random order. Overall, reproducibility was very good ( Figure S1 ). For HC, the mean difference was 0.0% and the 95% LoA were ± 3.3%. For AC, the mean difference was 0.0% and the 95% LoA were ± 5.6%. For FL, the mean difference was 0.0%; however, the 95% LoA, even when expressed as a percentage of FL, varied with gestational age, showing greater variability and poorer intraobserver reproducibility at lower gestational ages. On average, the 95% LoA for FL were ± 6.2% (Table 3 ). Interobserver variability was assessed using 1483 of the 1613 scans selected in the 10% QC sample as 130 remeasured scans were erased as a result of a technical problem. Overall, reproducibility was very good ( Figure S2 ). For HC, AC and FL, the mean difference was 1.0% or less, with 95% LoA of ± 4.4%, ± 6.0% and ± 5.6%, respectively (Table 3) .
Quantitative QC: data distribution
Comparisons with the expected distribution of measures showed no cause for concern in any biometric variable for 28 out of the 31 study sonographers. In one instance, a sonographer was found to have 16.5% of HC SDs and 11.1% of AC SDs outside the expected range, whilst two other sonographers demonstrated unacceptably high FL SDs (Figure 2) . In all three instances, retraining was undertaken and improvements were seen thereafter. The total number of images taken by these three sonographers made up only a very small proportion of the total dataset 
DISCUSSION
We report the implementation and results of using a comprehensive system to assess the quality of ultrasound images obtained from a large multicenter, international project. We not only demonstrate the system's feasibility, but show that it is possible to achieve a high level of reproducibility in such a study with the necessary QC measures.
Firstly, over 98% of the scored images were considered as high quality by both the local and USQU sonographers (qualitative QC); secondly, the intra-and interobserver reproducibility of measurements (quantitative QC) was high and within the limits of a previous study 14 (Table 3) ; and, thirdly, we monitored images and data regularly, which enabled us to identify a few sonographers whose performance fell outside expected standards, following which, corrective action was taken. It should be noted that this entire process relied upon initial training and standardization 1, 7, 19 -a crucial element of the project's success.
Meticulous standardization and ongoing monitoring of adherence to measurement protocols during data collection have been shown to ensure consistency and minimize systematic error in multicenter studies 1, 7, 11, 17 . In two recent systematic reviews of the literature relating to the creation of fetal crown-rump length and growth charts, no study reporting a comprehensive QC process was identified, which contributed undoubtedly to the poor quality of many existing studies 2, 3 . Our study has a number of strengths. Firstly, the QC strategy was designed and implemented prospectively 7, 15, 19 , and based firmly on previous studies that assessed the role of feedback on image 7 . For one sonographer (a), 3% of 365 triplicate measurements were above 97.5 th centile; for the other (b), 17% of 186 measurements were above accepted threshold, set at 10%, and retraining was undertaken. quality 7, 10, 23, 24 , and secondly, visual assessment of ultrasound images was based on an objective criterion-based scoring system, which has been shown to be significantly more reproducible than subjective methods 8, 25, 26 . In Salomon et al.'s 8 original description of this process, high reproducibility levels for the image scoring method were demonstrated (kappa between 0.60 and 0.98); despite undertaking QC in a blinded fashion, the results from our study were even better. The high level of reproducibility of such objective methods 9, 12, 25, 26 is corroborated by our study, which is the largest to date. It is likely that the high level of training of the sonographers acquiring the images and those conducting the QC, and the requirement for standardization of all staff in settings of near-optimal conditions for scanning contributed to the overall quality.
One of the limitations of the study is that only 10% of images underwent external scoring. However, this is the largest quality control program ever performed in the setting of a study on fetal growth. All images underwent self-scoring, and those that were scored externally were selected randomly, meaning that there was no evidence that a different proportion would have yielded different results. Of course, implementing such a QC strategy is labor intensive. While it is relatively easy to assess data distributions routinely 27 , external qualitative assessment using image scoring requires additional resources.
More cost-effective options might include voluntary submission of a small number of selected images (as, for example, in certification for nuchal translucency measurement) 28 ; however, the small number of images and the nature of self-selection mean that it is difficult to ascertain whether such images are truly representative of a sonographer's routine practice. Self-assessment of images correlates well with external scoring using a 10% random sample of all images, suggesting that it may also be a reasonable alternative. However, there are three reasons to be cautious. Firstly, we have demonstrated that self-scoring is effective in association with external scrutiny, and it is not known whether similarly high quality is achievable without a QC system. Secondly, such a system is feasible with a few highly trained and motivated sonographers and may not be scalable, for example, to a national screening program. Thirdly, while we have demonstrated excellent agreement between selfand external scoring across the whole dataset, the role of QC in screening is exception reporting, i.e. detecting individual outliers, rather than demonstrating that, on average, the system works. Only by integrating all the elements of our QC system were we able to identify opportunities for improvement that could not be detected by self-scoring alone. Automated methods for QC of routinely collected images are being studied and may, in the future, be the best option. These systems have the potential advantage of allowing all images to be assessed objectively and at low cost 29, 30 . Regarding quantitative QC, a literature search was performed to identify previous publications on the evaluation of reproducibility of fetal ultrasound biometry after 14 + 0 weeks (18 studies identified) 1, 14, 27, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . Studies were selected only if reliable quantitative values were calculated as LoA or repeatability coefficients 46, 47 . Overall intraobserver reproducibility reported 95% LoA of less than 4% (12 mm) for HC, 6% (12 mm) for AC and 7% (3 mm) for FL 1, 14, [32] [33] [34] [35] [36] [37] 40, 41, 43, 45 . Similarly, for interobserver analyses, 95% LoA for HC, AC and FL were within 4%, 6% and 6%, respectively 1, 14, 27, 31, [34] [35] [36] [37] [38] [39] 42, 44, 45 . Even though these studies were undertaken on smaller numbers of cases, mostly in single center research settings and without blinding of the measurements, these values are not markedly different from the results of our large-scale multicenter study.
Our study has shown that, in general, both intraand interobserver variability remain reasonably constant throughout pregnancy when reported as a percentage of fetal size. The exception is FL, for which increased variance was demonstrated at early gestational ages, most likely due to difficulty in accurately measuring FL when it is only 10-30 mm.
In conclusion, both qualitative and quantitative QC monitoring were found to be feasible in a large multicenter fetal growth study. The development of a standardized fetal biometric ultrasound measurement protocol, standardization of all sonographers (involving their training, assessment and certification), consistency and blinding of measurement are all necessary to minimize systematic error and ensure high reproducibility. Having developed a framework for ultrasound QC, we recommend that it is implemented in the future in similar research studies and, ideally, in clinical practice.
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